Pediatric Cancer
News and reporting on pediatric cancer.
The research hospital is working to further validate and refine its approach, aiming to arm clinicians with a more comprehensive tool to personalize care.
CHMP Recommends BMS's Augtyro for ROS1-Positive NSCLC, NTRK-Positive Tumors
The European Commission will decide whether to approve Augtyro in these two indications in January 2025.
CHOP, Brazilian National Cancer Institute to Bring Automated Cell Therapy Manufacturing to Brazil
The institutions will use a $4 million grant to launch a Rio de Janeiro-based center equipped with an automated closed-system CAR T-cell therapy platform.
Australian Universities, Cancer Institutes Form Victorian Paediatric Cancer Consortium
With A$45 million in funding, the group will focus on research developing safer therapies and clinical trial programs for pediatric cancer treatment.
Stanford Medicine Laboratory for Cell and Gene Medicine Awarded Grant for CAR T-Cell Platform
The lab will use the G-Rex platform to manufacture a CAR T-cell therapy for a Phase I clinical trial.
Jul 24, 2024
Jul 2, 2024
Mar 19, 2024
Dec 19, 2023